Divis Laboratories
Divis Laboratories
Shareholder Return: 3-year average, Sales Growth: 3-year Compounded Annual Growth Rate, Return On Equity: 3-year Return on Equity.
At a Glance
-
Shareholder Return143%
-
Sales Growth19%
-
Return on Equity27 %
Why Super 50
This active pharmaceutical ingredients (API) manufacturer headquartered in Hyderabad earns 90 percent of its revenues from exports, mainly to North America and Europe. With two US FDA-inspected manufacturing plants in Hyderabad and Visakhapatnam, the company is now planning a third manufacturing facility in Andhra Pradesh.
